137 related articles for article (PubMed ID: 3880875)
1. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
[TBL] [Abstract][Full Text] [Related]
2. Adenine metabolism in erythrocytes of patients with Duchenne muscular dystrophy.
Frass M; Toifl K; Leixnering W
Eur Neurol; 1983; 22(5):380-4. PubMed ID: 6628465
[TBL] [Abstract][Full Text] [Related]
3. Duchenne muscular dystrophy: normal ATP turnover in cultured cells.
Fox IH; Shefner R; Palmieri GM; Bertorini T
Adv Exp Med Biol; 1986; 195 Pt B():493-9. PubMed ID: 3766238
[TBL] [Abstract][Full Text] [Related]
4. Xanthine oxidase inhibitor in Duchenne muscular dystrophy.
Tamari H; Ohtani Y; Higashi A; Miyoshino S; Matsuda I
Brain Dev; 1982; 4(2):137-43. PubMed ID: 6896406
[TBL] [Abstract][Full Text] [Related]
5. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.
Stern LM; Fewings JD; Bretag AH; Ballard FJ; Tomas FM; Cooper DM; Goldblatt E
Neurology; 1981 Apr; 31(4):422-6. PubMed ID: 7012668
[TBL] [Abstract][Full Text] [Related]
6. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
Griffiths RD; Cady EB; Edwards RH; Wilkie DR
Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials of allopurinol in Duchenne muscular dystrophy.
Thomson WH
Med Hypotheses; 1985 Jun; 17(2):175-89. PubMed ID: 3897804
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic allopurinol therapy on purine metabolism in Duchenne muscular dystrophy.
Castro-Gago M; Lojo S; Novo I; del Rio R; Peña J; Rodriguez-Segade S
Biochem Biophys Res Commun; 1987 Aug; 147(1):152-7. PubMed ID: 2820393
[TBL] [Abstract][Full Text] [Related]
9. Increased adenine nucleotide turnover in duchenne muscular dystrophy.
Bertorini TE; Palmieri GM; Airozo D; Edwards NL; Fox IH
Pediatr Res; 1981 Dec; 15(12):1478-82. PubMed ID: 7322666
[TBL] [Abstract][Full Text] [Related]
10. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
[No Abstract] [Full Text] [Related]
11. Lack of benefit of allopurinol in Duchenne dystrophy.
Mendell JR; Wiechers DO
Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol ineffective in Duchenne muscular dystrophy.
Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
[No Abstract] [Full Text] [Related]
13. The purine nucleotide profile in mouse, chicken and human dystrophic muscle: an abnormal ratio of inosine plus adenine nucleotides to guanine nucleotides.
Shuttlewood RJ; Griffiths JR
Clin Sci (Lond); 1982 Jan; 62(1):113-5. PubMed ID: 7056028
[TBL] [Abstract][Full Text] [Related]
14. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy.
Camiña F; Novo-Rodriguez MI; Rodriguez-Segade S; Castro-Gago M
Clin Chim Acta; 1995 Dec; 243(2):151-64. PubMed ID: 8747491
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
[TBL] [Abstract][Full Text] [Related]
16. Effects of allopurinol in Duchenne's muscular dystrophy.
Hunter JR; Galloway JR; Brooke MM; Kutner MH; Rudman D; Vogel RL; Wardlaw CF; Gerron GG
Arch Neurol; 1983 May; 40(5):294-9. PubMed ID: 6847424
[TBL] [Abstract][Full Text] [Related]
17. Duchenne muscular dystrophy: normal ATP turnover in cultured cells.
Fox IH; Shefner R; Palmieri GM; Bertorini TE
Neurology; 1985 Oct; 35(10):1521-4. PubMed ID: 4033937
[TBL] [Abstract][Full Text] [Related]
18. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
Nakahara M
Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
[No Abstract] [Full Text] [Related]
19. Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy.
Bertorini TE; Palmieri GM; Griffin JW; Igarashi M; McGee J; Brown R; Nutting DF; Hinton AB; Karas JG
Neurology; 1988 Apr; 38(4):609-13. PubMed ID: 3281058
[TBL] [Abstract][Full Text] [Related]
20. X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: effects of oral allopurinol and adenylate.
Thomson WH
Adv Exp Med Biol; 1984; 165 Pt B():451-6. PubMed ID: 6539047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
